{{Drugbox
| verifiedrevid = 464389745
<!-- Monoclonal antibody data -->
| type = mab
| mab_type =  
| source = u
| target = [[cytomegalovirus|CMV]]
<!-- Clinical data -->
| tradename =  
| pregnancy_AU =  
| pregnancy_US =  
| pregnancy_category =  
| legal_AU =  
| legal_CA =  
| legal_UK =  
| legal_US =  
| legal_status =  
| routes_of_administration =  
<!-- Pharmacokinetic data -->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =  
<!-- Identifiers -->
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = none
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number =  
| ATC_prefix = none
| ATC_suffix =  
| PubChem =  
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  
<!-- Chemical data -->
| chemical_formula =  
| molecular_weight =  
}}

'''Sevirumab''' ('''MSL-109''') is a [[human]] [[monoclonal antibody]] for the treatment of infections with [[cytomegalovirus]] in patients with [[AIDS]].<ref>{{cite journal|pmid=15498605|year=2004|last1=Borucki|first1=MJ|last2=Spritzler|last3=Asmuth|last4=Gnann|last5=Hirsch|last6=Nokta|last7=Aweeka|last8=Nadler|last9=Sattler|title=A phase II, double-masked, randomized, placebo-controlled evaluation of a human monoclonal anti-Cytomegalovirus antibody (MSL-109) in combination with standard therapy versus standard therapy alone in the treatment of AIDS patients with Cytomegalovirus retinitis|volume=64|issue=2|pages=103â€“11|doi=10.1016/j.antiviral.2004.06.012|journal=Antiviral Research|first2=J|first3=DM|first4=J|first5=MS|first6=M|first7=F|first8=PI|first9=F|last10=Alston|first10=B|last11=Nevin|first11=T. T.|last12=Owens|first12=S|last13=Waterman|first13=K|last14=Hubbard|first14=L|last15=Caliendo|first15=A|last16=Pollard|first16=R. B.|last17=Aactg 266|first17=Team|display-authors=8}}</ref><ref>[http://www.clinicaltrials.gov/ct2/show/NCT00000836 ClinicalTrials.gov]</ref>

==References==
{{reflist}}

{{Monoclonals for infectious disease and toxins}}

[[Category:Monoclonal antibodies]]
[[Category:Experimental drugs]]


{{antiinfective-drug-stub}}
{{monoclonal-antibody-stub}}